Intravenous infusion of apolipoprotein E accelerates clearance of plasma lipoproteins in rabbits.

RW Mahley, KH Weisgraber… - The Journal of …, 1989 - Am Soc Clin Investig
RW Mahley, KH Weisgraber, MM Hussain, B Greenman, M Fisher, T Vogel, M Gorecki
The Journal of clinical investigation, 1989Am Soc Clin Investig
Plasma cholesterol levels in cholesterol-fed rabbits were markedly reduced by the
intravenous infusion or bolus injection of recombinant human apo E or rabbit plasma apo E.
Administration of 6-70 mg of apo E resulted in an approximately 20-40% acute reduction in
plasma cholesterol levels within 2-3 h. Plasma cholesterol levels remained reduced for 4-8 h
after the administration of apo E. Furthermore, the intravenous injection of apo E reduced the
plasma cholesterol levels in Watanabe heritable hyperlipidemic rabbits. The addition of apo …
Plasma cholesterol levels in cholesterol-fed rabbits were markedly reduced by the intravenous infusion or bolus injection of recombinant human apo E or rabbit plasma apo E. Administration of 6-70 mg of apo E resulted in an approximately 20-40% acute reduction in plasma cholesterol levels within 2-3 h. Plasma cholesterol levels remained reduced for 4-8 h after the administration of apo E. Furthermore, the intravenous injection of apo E reduced the plasma cholesterol levels in Watanabe heritable hyperlipidemic rabbits. The addition of apo E to [14C]cholesterol-labeled canine thoracic duct lymph or [14C]cholesterol-labeled chylomicrons resulted in accelerated plasma clearance of these diet-induced lipoproteins in normal rabbits, with the uptake occurring primarily in the liver. This study suggests that the amount or availability of apo E in the plasma of cholesterol-fed rabbits may be rate limiting for the normal clearance of diet-induced remnant lipoproteins.
The Journal of Clinical Investigation